What is the recommended treatment for trichomoniasis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Trichomoniasis

The recommended first-line treatment for trichomoniasis is metronidazole 2g orally in a single dose, which achieves cure rates of approximately 90-95%. 1, 2, 3

Treatment Options

  • Metronidazole 2g orally in a single dose is the preferred regimen due to ease of administration, better patient compliance, and high efficacy 4
  • Alternative regimen: metronidazole 500mg orally twice daily for 7 days, which may be more effective but requires longer treatment duration 4, 5
  • Metronidazole is the only oral medication available in the United States for the treatment of trichomoniasis 4, 6
  • Topical metronidazole gel is NOT effective for trichomoniasis (efficacy <50%) and should not be used 4, 1, 7

Management of Sexual Partners

  • All sexual partners should be treated simultaneously to prevent reinfection 4, 1, 2
  • Patients should abstain from sexual activity until both they and their partners complete treatment and are asymptomatic 4, 3
  • Treatment of partners is essential as trichomoniasis is a sexually transmitted disease that can lead to reinfection if partners are not treated 4, 1

Important Clinical Considerations

  • Metronidazole can cause a disulfiram-like reaction when combined with alcohol, including nausea, vomiting, flushing, headache, and abdominal cramps 1, 6
  • Patients should be advised to avoid alcohol during treatment and for at least 24 hours after completing metronidazole therapy 1, 3
  • Follow-up is unnecessary for patients who become asymptomatic after treatment 4, 2

Treatment Failure Management

  • For first treatment failure, re-treat with metronidazole 500mg twice daily for 7 days 4, 2
  • For repeated failure, administer metronidazole 2g once daily for 3-5 days 4, 2
  • If treatment continues to fail and reinfection has been excluded, consultation with an infectious disease specialist is recommended 4, 2
  • Consider susceptibility testing of T. vaginalis to metronidazole in persistent cases 1, 2

Special Populations

Pregnancy

  • Metronidazole 2g orally in a single dose is recommended after the first trimester 1, 2
  • Treatment is important as trichomoniasis has been associated with adverse pregnancy outcomes, including premature rupture of membranes and preterm delivery 4, 2

HIV Infection

  • Patients with HIV infection should receive the same treatment regimen as HIV-negative individuals 4, 1, 2

Metronidazole Allergy

  • For patients with true metronidazole allergy, desensitization may be required as effective alternatives are limited 4, 1, 3

Recent Evidence on Treatment Efficacy

  • A 2018 randomized controlled trial found that the 7-day metronidazole regimen (500mg twice daily) was more effective than the single 2g dose, with failure rates of 11% versus 19% respectively 5
  • Despite this recent evidence, most guidelines still recommend the single 2g dose as first-line therapy due to its convenience, cost-effectiveness, and high compliance rates 1, 2, 3
  • The decision between single-dose and 7-day therapy may be influenced by concerns about adherence, with single-dose being preferable when adherence is a concern 3, 8

References

Guideline

Treatment of Trichomoniasis in Patients Consuming Alcohol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Trichomoniasis Vaginal Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Trichomonas Infection Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.